23 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26762835	342	Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2).	Icahn School Of Medicine At Mount Sinai
26385444	74	Design, synthesis and pharmacological evaluation of pyrimidobenzothiazole-3-carboxylate derivatives as selective L-type calcium channel blockers.	Rashtrasant Tukadoji Maharaj Nagpur University
25589925	13	Fragment-based discovery of type I inhibitors of maternal embryonic leucine zipper kinase.	Astex Pharmaceuticals
22819505	46	Discovery and characterization of novel allosteric FAK inhibitors.	Takeda Pharmaceutical
24936234	42	Synthesis and biological evaluation of a selective N- and p/q-type calcium channel agonist.	TBA
18183025	12060	A quantitative analysis of kinase inhibitor selectivity.	Ambit Biosciences
17850214	99	The selectivity of protein kinase inhibitors: a further update.	University Of Dundee
18077363	314	A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.	University Of Oxford
12672248	50	Kinase inhibitors: not just for kinases anymore.	Northwestern University
21999461	90	1,7-Naphthyridine 1-oxides as novel potent and selective inhibitors of p38 mitogen activated protein kinase.	RhôNe-Poulenc Rorer
22037378	31824	Comprehensive analysis of kinase inhibitor selectivity.	Ambit Biosciences
21130659	19	Synthesis and biological evaluation of 7-substituted-1-(3-bromophenylamino)isoquinoline-4-carbonitriles as inhibitors of myosin light chain kinase and epidermal growth factor receptor.	Chemical Genomics Centre Of The Max Planck Society
20875738	9	5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors.	Dainippon Sumitomo Pharma
19654408	2521	AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).	Ambit Biosciences
17632515	13	Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR.	Novartis Institutes For Biomedical Research
19035792	85	Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.	Glaxosmithkline
16441060	12	A common protein fold topology shared by flavonoid biosynthetic enzymes and therapeutic targets.	Griffith University
12270156	8	Synthesis and kinase inhibitory activity of 3'-(S)-epi-K-252a.	Cephalon
21270126	3	Combined X-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335.	Boehringer Ingelheim (Canada)
18393489	11	Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine a.	University Of British Columbia